{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-043036","form_type":"8-K","ticker":"KTTA","cik":"0001841330","company_name":"Pasithea Therapeutics Corp.","filed_at":"2024-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.675804+00:00","generated_at":"2026-06-02T01:12:52.695246+00:00","sec_items":["5.08"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Pasithea Therapeutics schedules 2024 Annual Meeting for June 26, 2024; sets May 24 shareholder proposal deadline.","bullets":["Annual meeting via internet on June 26, 2024 at 9:00 a.m. ET; record date April 29, 2024.","Deadline for Rule 14a-8 shareholder proposals for proxy inclusion is May 24, 2024.","Proposals must be mailed to company's Miami Beach, FL address.","No other material updates in the filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-043036","json":"https://secwatch.observer/filing/0001213900-24-043036.json","markdown":"https://secwatch.observer/filing/0001213900-24-043036.md","text":"https://secwatch.observer/filing/0001213900-24-043036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1841330/000121390024043036/0001213900-24-043036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1841330/000121390024043036/ea0205945-8k_pasithea.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T01:12:52.695246+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}